BONESUPPORT HOLDING AB (BOEUF)
23.00
0.00 (0.00%)
USD |
OTCM |
Oct 08, 16:00
BONESUPPORT Profit Margin (Quarterly) : 23.02% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 23.02% |
| March 31, 2026 | 16.47% |
| December 31, 2025 | 14.13% |
| September 30, 2025 | 11.73% |
| June 30, 2025 | 18.66% |
| March 31, 2025 | 3.68% |
| December 31, 2024 | 20.98% |
| September 30, 2024 | 12.87% |
| June 30, 2024 | 12.48% |
| March 31, 2024 | 11.85% |
| December 31, 2023 | 6.21% |
| September 30, 2023 | |
| June 30, 2023 | 3.71% |
| March 31, 2023 | 0.26% |
| December 31, 2022 | -19.90% |
| September 30, 2022 | -17.67% |
| June 30, 2022 | -21.84% |
| March 31, 2022 | -24.68% |
| December 31, 2021 | -39.42% |
| September 30, 2021 | -25.64% |
| June 30, 2021 | -52.23% |
| Date | Value |
|---|---|
| March 31, 2021 | -45.09% |
| December 31, 2020 | -51.09% |
| September 30, 2020 | -44.16% |
| June 30, 2020 | -65.33% |
| March 31, 2020 | -67.65% |
| December 31, 2019 | -88.42% |
| September 30, 2019 | -84.85% |
| June 30, 2019 | -128.5% |
| March 31, 2019 | -119.0% |
| December 31, 2018 | -197.4% |
| September 30, 2018 | -412.7% |
| June 30, 2018 | -135.6% |
| March 31, 2018 | -108.7% |
| December 31, 2017 | -189.9% |
| September 30, 2017 | -70.04% |
| June 30, 2017 | -63.41% |
| March 31, 2017 | -95.79% |
| December 31, 2016 | -116.9% |
| September 30, 2016 | -131.2% |
| June 30, 2016 | -92.47% |
| March 31, 2016 | -75.05% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| BioInvent International AB | -964.0% |
| Hansa Biopharma AB | -541.7% |
| BioArctic AB | -4.51% |
| Swedish Orphan Biovitrum AB | 14.00% |
| Diamyd Medical AB | -184.8K% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 24.72% |
| Return on Assets | 20.67% |
| Return on Invested Capital | 24.39% |
| Gross Profit Margin (Quarterly) | 90.81% |
| Operating Margin (Quarterly) | 23.92% |
| Return on Net Operating Assets | 55.43% |